These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 25347203

  • 1. A new class of peptidomimetics targeting the polo-box domain of Polo-like kinase 1.
    Ahn M, Han YH, Park JE, Kim S, Lee WC, Lee SJ, Gunasekaran P, Cheong C, Shin SY, Kim HY, Ryu EK, Murugan RN, Kim NH, Bang JK.
    J Med Chem; 2015 Jan 08; 58(1):294-304. PubMed ID: 25347203
    [Abstract] [Full Text] [Related]

  • 2. Novel Macrocyclic Peptidomimetics Targeting the Polo-Box Domain of Polo-Like Kinase 1.
    Ryu S, Park JE, Ham YJ, Lim DC, Kwiatkowski NP, Kim DH, Bhunia D, Kim ND, Yaffe MB, Son W, Kim N, Choi TI, Swain P, Kim CH, Lee JY, Gray NS, Lee KS, Sim T.
    J Med Chem; 2022 Feb 10; 65(3):1915-1932. PubMed ID: 35029981
    [Abstract] [Full Text] [Related]

  • 3. Identification of green tea catechins as potent inhibitors of the polo-box domain of polo-like kinase 1.
    Shan HM, Shi Y, Quan J.
    ChemMedChem; 2015 Jan 10; 10(1):158-63. PubMed ID: 25196850
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis and evaluation of d-amino acid-containing peptidomimetics targeting the polo-box domain of polo-like kinase 1.
    Li Z, Zhang Z, Chen Y, Tang S, Lin T, Huang J, Li B, Jiang C.
    Bioorg Chem; 2019 Apr 10; 85():534-540. PubMed ID: 30807896
    [Abstract] [Full Text] [Related]

  • 5. Enhancing polo-like kinase 1 selectivity of polo-box domain-binding peptides.
    Zhao XZ, Hymel D, Burke TR.
    Bioorg Med Chem; 2017 Oct 01; 25(19):5041-5049. PubMed ID: 28285924
    [Abstract] [Full Text] [Related]

  • 6. Peptidomimetic Polo-Box-Targeted Inhibitors that Engage PLK1 in Tumor Cells and Are Selective against the PLK3 Tumor Suppressor.
    Baxter M, Chapagai D, Craig S, Hurtado C, Varghese J, Nurmemmedov E, Wyatt MD, McInnes C.
    ChemMedChem; 2020 Jun 17; 15(12):1058-1066. PubMed ID: 32232973
    [Abstract] [Full Text] [Related]

  • 7. Identification of novel peptidomimetics targeting the polo-box domain of polo-like kinase 1.
    Li Z, Zhang Z, Sun H, Xu L, Jiang C.
    Bioorg Chem; 2019 Oct 17; 91():103148. PubMed ID: 31376784
    [Abstract] [Full Text] [Related]

  • 8. Enhanced cellular uptake of a TAT-conjugated peptide inhibitor targeting the polo-box domain of polo-like kinase 1.
    Kim SM, Chae MK, Lee C, Yim MS, Bang JK, Ryu EK.
    Amino Acids; 2014 Nov 17; 46(11):2595-603. PubMed ID: 25151148
    [Abstract] [Full Text] [Related]

  • 9. Identification of acylthiourea derivatives as potent Plk1 PBD inhibitors.
    Yun T, Qin T, Liu Y, Lai L.
    Eur J Med Chem; 2016 Nov 29; 124():229-236. PubMed ID: 27592392
    [Abstract] [Full Text] [Related]

  • 10. Design and synthesis of a cell-permeable, drug-like small molecule inhibitor targeting the polo-box domain of polo-like kinase 1.
    Srinivasrao G, Park JE, Kim S, Ahn M, Cheong C, Nam KY, Gunasekaran P, Hwang E, Kim NH, Shin SY, Lee KS, Ryu E, Bang JK.
    PLoS One; 2014 Nov 29; 9(9):e107432. PubMed ID: 25211362
    [Abstract] [Full Text] [Related]

  • 11. A high-throughput assay based on fluorescence polarization for inhibitors of the polo-box domain of polo-like kinase 1.
    Reindl W, Strebhardt K, Berg T.
    Anal Biochem; 2008 Dec 15; 383(2):205-9. PubMed ID: 18793607
    [Abstract] [Full Text] [Related]

  • 12. Development of Bifunctional Inhibitors of Polo-Like Kinase 1 with Low-Nanomolar Activities Against the Polo-Box Domain.
    Scharow A, Knappe D, Reindl W, Hoffmann R, Berg T.
    Chembiochem; 2016 Apr 15; 17(8):759-67. PubMed ID: 26634982
    [Abstract] [Full Text] [Related]

  • 13. Inhibitors of the Polo-Box Domain of Polo-Like Kinase 1.
    Berg A, Berg T.
    Chembiochem; 2016 Apr 15; 17(8):650-6. PubMed ID: 26662918
    [Abstract] [Full Text] [Related]

  • 14. Structural basis for recognition of Emi2 by Polo-like kinase 1 and development of peptidomimetics blocking oocyte maturation and fertilization.
    Jia JL, Han YH, Kim HC, Ahn M, Kwon JW, Luo Y, Gunasekaran P, Lee SJ, Lee KS, Kyu Bang J, Kim NH, Namgoong S.
    Sci Rep; 2015 Oct 13; 5():14626. PubMed ID: 26459104
    [Abstract] [Full Text] [Related]

  • 15. Identification of nitroimidazole-oxime derivatives targeting the polo-box domain of polo-like kinase 1.
    Sun J, Liu HY, Xu RF, Zhu HL.
    Bioorg Med Chem; 2017 Dec 15; 25(24):6581-6588. PubMed ID: 29100732
    [Abstract] [Full Text] [Related]

  • 16. Phosphopeptides with improved cellular uptake properties as ligands for the polo-box domain of polo-like kinase 1.
    Richter S, Neundorf I, Loebner K, Gräber M, Berg T, Bergmann R, Steinbach J, Pietzsch J, Wuest F.
    Bioorg Med Chem Lett; 2011 Aug 15; 21(16):4686-9. PubMed ID: 21778054
    [Abstract] [Full Text] [Related]

  • 17. Identification of a novel Polo-like kinase 1 inhibitor that specifically blocks the functions of Polo-Box domain.
    Chen Y, Zhang J, Li D, Jiang J, Wang Y, Si S.
    Oncotarget; 2017 Jan 03; 8(1):1234-1246. PubMed ID: 27902479
    [Abstract] [Full Text] [Related]

  • 18. Peptide-based inhibitors of Plk1 polo-box domain containing mono-anionic phosphothreonine esters and their pivaloyloxymethyl prodrugs.
    Qian WJ, Park JE, Lim D, Park SY, Lee KW, Yaffe MB, Lee KS, Burke TR.
    Chem Biol; 2013 Oct 24; 20(10):1255-64. PubMed ID: 24120332
    [Abstract] [Full Text] [Related]

  • 19. Identification of high affinity polo-like kinase 1 (Plk1) polo-box domain binding peptides using oxime-based diversification.
    Liu F, Park JE, Qian WJ, Lim D, Scharow A, Berg T, Yaffe MB, Lee KS, Burke TR.
    ACS Chem Biol; 2012 May 18; 7(5):805-10. PubMed ID: 22292814
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis, and evaluation of non-ATP-competitive small-molecule Polo-like kinase 1 (Plk1) inhibitors.
    Chen DX, Huang J, Liu M, Xu YG, Jiang C.
    Arch Pharm (Weinheim); 2015 Jan 18; 348(1):2-9. PubMed ID: 25430493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.